Carl Icahn - Icahn Carl C
Holding/activity history for Enzon Pharmaceuticals Inc (EZ1)
| Period | Shares | % of Portfolio | Activity | % Change to Portfolio | Reported Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2016 Q2 | 0 | 0.00 | Sell 100.00% | 0.01 | SEC | ||
| 2016 Q1 | 5,904,863 | 0.01 | $0.47 | $2,775,000 | SEC | ||
| 2015 Q4 | 5,904,863 | 0.01 | $0.68 | $4,030,000 | SEC | ||
| 2015 Q3 | 5,904,863 | 0.02 | $0.97 | $5,728,000 | SEC | ||
| 2015 Q2 | 5,904,863 | 0.03 | $1.20 | $7,086,000 | SEC | ||
| 2015 Q1 | 5,904,863 | 0.03 | $1.06 | $6,259,000 | SEC | ||
| 2014 Q4 | 5,904,863 | 0.03 | $1.09 | $6,436,000 | SEC | ||
| 2014 Q3 | 5,904,863 | 0.02 | $1.08 | $6,377,000 | SEC | ||
| 2014 Q2 | 5,904,863 | 0.02 | $1.04 | $6,141,000 | SEC | ||
| 2014 Q1 | 5,904,863 | 0.02 | $1.03 | $6,082,000 | SEC | ||
| 2013 Q4 | 5,904,863 | 0.02 | $1.16 | $6,850,000 | SEC | ||
| 2013 Q3 | 5,904,863 | 0.04 | $1.68 | $9,920,000 | SEC | ||
| 2013 Q2 | 5,904,863 | 0.05 | $2.00 | $11,810,000 | SEC | ||
| 2013 Q1 | 5,904,863 | 0.13 | $3.80 | $22,439,000 | SEC | ||
| 2012 Q4 | 5,904,863 | 0.20 | $4.43 | $26,159,000 | SEC | ||
| 2012 Q3 | 5,904,863 | 0.37 | $6.96 | $41,098,000 | SEC | ||
| 2012 Q2 | 5,904,863 | 0.40 | $6.87 | $40,566,000 | SEC | ||
| 2012 Q1 | 5,904,863 | 0.43 | $6.84 | $40,389,000 | SEC | ||
| 2011 Q4 | 5,904,863 | 0.34 | $6.70 | $39,563,000 | SEC | ||
| 2011 Q3 | 5,904,863 | 0.37 | $7.04 | $41,570,000 | SEC | ||
| 2011 Q2 | 5,904,863 | 0.54 | Add 400.00% | 0.43 | $10.05 | $59,344,000 | SEC |
| 2011 Q1 | 1,180,972 | 0.19 | $10.90 | $12,873,000 | SEC | ||
| 2010 Q4 | 1,180,972 | 0.25 | Add 67.70% | 0.10 | $12.17 | $14,372,000 | SEC |
| 2010 Q3 | 704,214 | 0.14 | $11.25 | $7,922,000 | SEC | ||
| 2010 Q2 | 704,214 | 0.16 | $10.65 | $7,500,000 | SEC | ||
| 2010 Q1 | 704,214 | 0.13 | $10.18 | $7,169,000 | SEC | ||
| 2009 Q4 | 704,214 | 0.17 | $10.53 | $7,415,000 | SEC | ||
| 2009 Q2 | 704,214 | 0.14 | Add 14.61% | 0.02 | $7.87 | $5,542,000 | SEC |
| 2008 Q4 | 614,420 | 0.14 | $5.83 | $3,582,000 | SEC | ||
| 2008 Q3 | 614,420 | 0.09 | Buy | 0.09 | $7.38 | $4,534,000 | SEC |